Page last updated: 2024-10-23

bisindolylmaleimide i and Prostatic Hyperplasia

bisindolylmaleimide i has been researched along with Prostatic Hyperplasia in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.

Research Excerpts

ExcerptRelevanceReference
"Prostate smooth muscle contraction is promoted by receptor-induced activation of intracellular signaling pathways."5.72Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983. ( Hennenberg, M; Huang, R; Li, B; Liu, Y; Stief, CG; Strittmatter, F; Tamalunas, A; Waidelich, R; Wang, R, 2022)
"Prostate smooth muscle contraction is promoted by receptor-induced activation of intracellular signaling pathways."1.72Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983. ( Hennenberg, M; Huang, R; Li, B; Liu, Y; Stief, CG; Strittmatter, F; Tamalunas, A; Waidelich, R; Wang, R, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, R1
Liu, Y1
Li, B1
Wang, R1
Tamalunas, A1
Waidelich, R1
Strittmatter, F1
Stief, CG1
Hennenberg, M1

Other Studies

1 other study available for bisindolylmaleimide i and Prostatic Hyperplasia

ArticleYear
Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
    The Prostate, 2022, Volume: 82, Issue:1

    Topics: Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Maleimides; Muscle Contraction

2022